Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Oakland › NPI 1295181477
Lab

Sutter Bay Hospitals

Sutter Bay Hospitals was paid $46.80M by Medicaid between Mar 2018 and Dec 2024, across 244 billing codes. Its largest line is 99284, emergency room visit (serious) — 12% of everything it billed.

33Billing provider infoSUTTER BAY HOSPITALS
OAKLAND, CA 94609
33aNPI1295181477assigned 05/06/2016
33bProvider typeClinical Medical Laboratory
28Total paid$46.80M
24GClaims798,449
24DCodes billed244
24AFirst – last monthMar 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#22 of 561
Median peer was paid$222K
This provider vs. median211×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official GATES, JOHN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201899,730$6.63M
2019116,950$8.41M
202097,259$5.34M
2021107,083$5.93M
2022103,780$5.69M
2023131,490$6.98M
2024incomplete142,157$7.83M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 12% 63,430 54,676 $5.58M
0111 10% 262 232 $4.78M
77067 Screening mammography, bilateral, including computer-aided detection 7.6% 22,491 22,347 $3.57M
70450 Computed tomography, head or brain; without contrast material 4.7% 8,936 8,588 $2.19M
74177 Computed tomography, abdomen and pelvis; with contrast material 3.8% 5,980 5,810 $1.79M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.7% 18,366 16,927 $1.73M
76700 Ultrasound, abdominal, real time with image documentation; complete 2.6% 10,457 10,307 $1.21M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.5% 32,031 29,027 $1.18M
99199 Unlisted special service, procedure or report 2.1% 9,776 8,270 $987K
80053 Comprehensive metabolic panel 2.0% 53,077 47,605 $918K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.9% 7,263 6,846 $880K
0450 Emergency room services 1.9% 11,195 9,876 $878K
232 more codes
96375 Therapeutic injection; each additional sequential IV push 1.8% 13,538 $854K
J3490 Unclassified drugs 1.7% 23,990 $797K
99231 Subsequent hospital care, per day, straightforward or low complexity 1.6% 12,123 $741K
77066 Tomosynthesis, mammo 1.6% 4,440 $729K
0250 1.5% 5,538 $718K
99070 1.5% 20,515 $703K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.3% 6,488 $607K
76642 1.1% 6,314 $521K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 1.0% 2,309 $486K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.0% 10,720 $484K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 1.0% 4,498 $477K
71275 Computed tomographic angiography, chest, with contrast material 1.0% 1,782 $475K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 54,936 $463K
82077 <1% 4,317 $442K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 2,175 $421K
77063 Screening digital breast tomosynthesis, bilateral <1% 10,513 $416K
71045 Radiologic examination, chest; single view <1% 20,263 $405K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 6,104 $404K
99285 Emergency room visit (most serious) <1% 2,950 $384K
96361 Intravenous infusion, hydration; each additional hour <1% 7,156 $383K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 2,373 $372K
77065 Tomosynthesis, mammo <1% 2,646 $358K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 3,613 $349K
72125 Computed tomography, cervical spine; without contrast material <1% 1,113 $325K
76830 Ultrasound, transvaginal <1% 3,241 $319K
71250 <1% 1,550 $312K
93971 <1% 2,009 $302K
84484 <1% 23,051 $244K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 9,109 $241K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 17,193 $232K
0214 <1% 27 $226K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 2,428 $218K
76981 <1% 2,024 $214K
71046 Radiologic examination, chest; 2 views <1% 6,370 $213K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 5,776 $188K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 728 $187K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 3,142 $173K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 3,139 $172K
97802 <1% 1,004 $171K
76770 <1% 1,659 $167K
83880 <1% 4,664 $159K
J7030 Infusion, normal saline solution , 1000 cc <1% 13,674 $159K
G0297 Low dose ct scan (ldct) for lung cancer screening <1% 531 $157K
99283 Emergency room visit (moderate) <1% 2,695 $149K
76536 <1% 1,599 $136K
83690 <1% 14,973 $119K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 2,126 $114K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 241 $110K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 8,335 $96K
0301 <1% 499 $92K
97803 <1% 905 $90K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 1,842 $90K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,712 $86K
71271 <1% 557 $85K
77080 <1% 1,509 $82K
86803 <1% 3,749 $80K
87086 Culture, bacterial; quantitative colony count, urine <1% 7,873 $80K
76801 <1% 862 $75K
T1999 Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" <1% 4,080 $74K
76999 <1% 279 $72K
73030 <1% 1,802 $71K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 804 $71K
87040 <1% 5,893 $71K
83605 <1% 5,769 $70K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,975 $68K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 645 $68K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 266 $67K
73562 <1% 1,895 $66K
70496 <1% 271 $66K
J2270 Injection, morphine sulfate, up to 10 mg <1% 4,659 $62K
70498 <1% 279 $61K
84702 <1% 3,741 $60K
86703 <1% 3,640 $59K
70486 <1% 208 $58K
72100 <1% 1,331 $57K
0510 <1% 1,115 $55K
81001 <1% 14,252 $54K
73610 <1% 1,302 $51K
94729 <1% 857 $49K
84703 <1% 6,651 $49K
73630 <1% 1,334 $49K
J1953 Injection, levetiracetam, 10 mg <1% 559 $49K
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,654 $47K
84443 Thyroid stimulating hormone (TSH) <1% 2,324 $46K
83735 <1% 5,910 $45K
90715 <1% 796 $45K
72131 <1% 174 $43K
74174 <1% 143 $41K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 79 $40K
93970 <1% 182 $40K
73130 <1% 1,014 $40K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 253 $37K
85610 <1% 8,382 $36K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,165 $35K
J1170 Injection, hydromorphone, up to 4 mg <1% 2,118 $35K
73502 <1% 727 $34K
85730 <1% 4,978 $33K
0306 <1% 336 $32K
93017 <1% 521 $32K
90653 <1% 269 $32K
81025 <1% 5,321 $32K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 370 $31K
74240 <1% 300 $31K
90662 <1% 342 $30K
80047 <1% 1,787 $30K
94010 <1% 708 $28K
0305 <1% 356 $28K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,898 $26K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,813 $26K
87077 <1% 2,814 $26K
80143 <1% 195 $26K
82947 <1% 3,807 $25K
80048 Basic metabolic panel (calcium, ionized) <1% 1,986 $25K
87186 <1% 2,593 $24K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 697 $24K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,890 $24K
99221 <1% 221 $23K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 1,522 $22K
94727 <1% 527 $21K
J1815 Injection, insulin, per 5 units <1% 440 $20K
S0164 Injection, pantoprazole sodium, 40 mg <1% 1,055 $19K
81003 <1% 6,662 $19K
96367 <1% 310 $19K
87081 <1% 1,974 $17K
85379 <1% 1,319 $17K
J2060 Injection, lorazepam, 2 mg <1% 1,670 $16K
J2704 Injection, propofol, 10 mg <1% 423 $15K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,647 $14K
0270 <1% 375 $13K
99232 Hospital visit by a doctor, follow-up day <1% 51 $13K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 172 $13K
94726 <1% 174 $13K
83036 Hemoglobin; glycosylated (A1C) <1% 882 $13K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,425 $13K
91322 <1% 47 $13K
76775 <1% 131 $12K
86900 <1% 2,655 $10K
82607 <1% 512 $10K
J1171 Injection, hydromorphone, 0.1 mg <1% 113 $10K
86901 <1% 2,515 $10K
86850 <1% 1,615 $10K
70491 <1% 25 $10K
96376 <1% 257 $10K
90651 <1% 27 $10K
84439 <1% 889 $9K
73110 <1% 216 $9K
87210 <1% 1,625 $9K
J1940 Injection, furosemide, up to 20 mg <1% 623 $9K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 16 $8K
0360 <1% 56 $8K
85027 <1% 1,155 $8K
0760 <1% 126 $8K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 174 $8K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 763 $7K
80061 Lipid panel <1% 455 $7K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 115 $7K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 407 $7K
82728 <1% 336 $7K
72040 <1% 169 $6K
80179 <1% 85 $6K
90686 <1% 158 $6K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 132 $6K
J3486 Injection, ziprasidone mesylate, 10 mg <1% 151 $5K
85014 <1% 1,852 $5K
84425 <1% 360 $5K
83540 <1% 550 $5K
82550 <1% 583 $5K
74246 <1% 39 $5K
73560 <1% 135 $4K
94060 <1% 56 $4K
0324 <1% 94 $3K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 54 $3K
Z7502 <1% 88 $3K
87400 <1% 323 $3K
74018 <1% 70 $3K
0730 <1% 115 $3K
86592 <1% 352 $2K
94644 <1% 71 $2K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 75 $2K
71101 <1% 28 $2K
87522 Neg quan hep c or qual rna <1% 37 $2K
76870 <1% 25 $2K
36415 Collection of venous blood by venipuncture <1% 1,151 $2K
73590 <1% 66 $2K
0124A <1% 49 $2K
84145 <1% 95 $2K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 19 $2K
0258 <1% 123 $2K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 235 $2K
A9585 Injection, gadobutrol, 0.1 ml <1% 40 $2K
J3475 Injection, magnesium sulfate, per 500 mg <1% 59 $2K
96368 <1% 51 $2K
0001A <1% 33 $1K
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 35 $1K
72110 <1% 17 $1K
0710 <1% 29 $1K
J0360 Injection, hydralazine hcl, up to 20 mg <1% 81 $1K
J2470 Injection, pantoprazole sodium, 40 mg <1% 185 $1K
J7050 Infusion, normal saline solution, 250 cc <1% 63 $1K
84132 <1% 286 $1K
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 868 $1K
84100 <1% 209 $1K
J2785 Injection, regadenoson, 0.1 mg <1% 12 $840.00
0272 <1% 27 $781.19
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg <1% 223 $701.78
0949 <1% 13 $684.00
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 16 $653.12
S9470 Nutritional counseling, dietitian visit <1% 12 $642.72
99218 <1% 13 $632.30
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 40 $608.16
73080 <1% 15 $581.67
J0690 Injection, cefazolin sodium, 500 mg <1% 45 $543.46
0300 <1% 88 $527.04
90472 Immunization administration, each additional vaccine (list separately) <1% 48 $501.89
72070 <1% 13 $493.15
87147 <1% 69 $440.42
J3370 Injection, vancomycin hcl, 500 mg <1% 14 $384.02
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 17 $375.00
73140 <1% 15 $367.78
S0028 Injection, famotidine, 20 mg <1% 89 $366.08
36591 <1% 25 $308.36
85651 <1% 94 $270.61
J0780 Injection, prochlorperazine, up to 10 mg <1% 16 $198.36
84590 <1% 16 $197.92
84630 <1% 16 $196.32
0307 <1% 49 $160.19
87088 <1% 12 $83.86
0255 <1% 12 $67.46
0420 <1% 18 $23.21
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 28 $6.84
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 29 $1.85
0250R 0% 384 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGATES, JOHN (CFO)
Same official

Other billing entities under GATES, JOHN

Full network →
ProviderLocationPaid
Sutter Bay HospitalsCastro Valley, CA$52.65M
Sutter Bay HospitalsBerkeley, CA$43.78M
Sutter Bay HospitalsLakeport, CA$39.50M
Sutter Bay HospitalsSanta Rosa, CA$35.23M
Sutter Bay HospitalsAntioch, CA$29.48M
Sutter Bay HospitalsSan Francisco, CA$19.99M
Sutter Bay HospitalsBurlingame, CA$17.15M
Sutter Bay HospitalsSan Francisco, CA$14.94M
Sutter Bay HospitalsNovato, CA$11.12M
Sutter Bay HospitalsSan Francisco, CA$6.79M
Sutter Bay HospitalsLakeport, CA$3.99M
Sutter East Bay HospitalsAntioch, CA$3.45M
Sutter Bay HospitalsBurlingame, CA$1.98M
Sutter Bay HospitalsLakeport, CA$1.72M
Sutter East Bay HospitalsOakland, CA$1.10M
Sutter Bay HospitalsSan Francisco, CA$1.08M
Sutter East Bay HospitalsBerkeley, CA$946K
Sutter West Bay HospitalsSan Francisco, CA$186K
Magnetic Imaging Affiliates, LLCOakland, CA$112K
Sutter Bay HospitalsBerkeley, CA$45K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.